- Home
- RGNX vs CGBD Comparison
RGNX vs CGBD Comparison
Compare RGNX & CGBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RGNX | CGBD |
|---|---|---|
| Founded | 2008 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 761.9M | 913.5M |
| IPO Year | 2015 | 2017 |
Fundamental Metrics
Financial Performance| Metric | RGNX | CGBD |
|---|---|---|
| Price | $14.94 | $12.94 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 7 |
| Target Price | ★ $30.78 | $13.70 |
| AVG Volume (30 Days) | ★ 706.5K | 507.5K |
| Earning Date | 03-12-2026 | 02-24-2026 |
| Dividend Yield | N/A | ★ 12.95% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.14 |
| Revenue | $161,318,000.00 | ★ $245,008,000.00 |
| Revenue This Year | $133.58 | $12.93 |
| Revenue Next Year | $45.08 | $3.04 |
| P/E Ratio | ★ N/A | $11.20 |
| Revenue Growth | ★ 91.30 | 2.55 |
| 52 Week Low | $5.04 | $11.55 |
| 52 Week High | $15.84 | $18.64 |
Technical Indicators
Market Signals| Indicator | RGNX | CGBD |
|---|---|---|
| Relative Strength Index (RSI) | 57.11 | 56.81 |
| Support Level | $13.40 | $12.63 |
| Resistance Level | $15.31 | $12.98 |
| Average True Range (ATR) | 0.96 | 0.29 |
| MACD | -0.08 | 0.03 |
| Stochastic Oscillator | 70.71 | 95.21 |
Price Performance
Historical ComparisonAbout RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.
About CGBD Carlyle Secured Lending Inc.
Carlyle Secured Lending Inc is a specialty finance company that is a closed-end, externally managed, non-diversified management investment company. It focuses on providing directly originated, financing solutions across the capital structure, with a focus on senior secured lending to middle-market companies located in the United States. The company's investment objective is to generate current income and capital appreciation through debt investments in U.S. middle-market companies.